These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27647218)

  • 1. Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia.
    Kort NS; Ford JM; Roach BJ; Gunduz-Bruce H; Krystal JH; Jaeger J; Reinhart RM; Mathalon DH
    Biol Psychiatry; 2017 Mar; 81(6):514-524. PubMed ID: 27647218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient auditory predictive coding during vocalization in the psychosis risk syndrome and in early illness schizophrenia: the final expanded sample.
    Mathalon DH; Roach BJ; Ferri JM; Loewy RL; Stuart BK; Perez VB; Trujillo TH; Ford JM
    Psychol Med; 2019 Aug; 49(11):1897-1904. PubMed ID: 30249315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theta Phase Synchrony Is Sensitive to Corollary Discharge Abnormalities in Early Illness Schizophrenia but Not in the Psychosis Risk Syndrome.
    Roach BJ; Ford JM; Loewy RL; Stuart BK; Mathalon DH
    Schizophr Bull; 2021 Mar; 47(2):415-423. PubMed ID: 32793958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-D-aspartate receptor antagonism impairs sensory gating in the auditory cortex in response to speech stimuli.
    de la Salle S; Choueiry J; McIntosh J; Bowers H; Ilivitsky V; Knott V
    Psychopharmacology (Berl); 2022 Jul; 239(7):2155-2169. PubMed ID: 35348805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia.
    Holcomb HH; Lahti AC; Medoff DR; Cullen T; Tamminga CA
    Neuropsychopharmacology; 2005 Dec; 30(12):2275-82. PubMed ID: 16034443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efference copy/corollary discharge function and targeted cognitive training in patients with schizophrenia.
    Roach BJ; Ford JM; Biagianti B; Hamilton HK; Ramsay IS; Fisher M; Loewy R; Vinogradov S; Mathalon DH
    Int J Psychophysiol; 2019 Nov; 145():91-98. PubMed ID: 30599145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Prefrontal Disinhibition in a Roving Auditory Oddball Paradigm Under N-Methyl-D-Aspartate Receptor Blockade.
    Rosch RE; Auksztulewicz R; Leung PD; Friston KJ; Baldeweg T
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Feb; 4(2):140-150. PubMed ID: 30115499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-d-aspartate receptor antagonism modulates P300 event-related potentials and associated activity in salience and central executive networks.
    de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Carroll B; Ilivitsky V; Knott V
    Pharmacol Biochem Behav; 2021 Dec; 211():173287. PubMed ID: 34653398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia.
    Grent-'t-Jong T; Rivolta D; Gross J; Gajwani R; Lawrie SM; Schwannauer M; Heidegger T; Wibral M; Singer W; Sauer A; Scheller B; Uhlhaas PJ
    Brain; 2018 Aug; 141(8):2511-2526. PubMed ID: 30020423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
    Umbricht D; Koller R; Vollenweider FX; Schmid L
    Biol Psychiatry; 2002 Mar; 51(5):400-6. PubMed ID: 11904134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine Affects Prediction Errors about Statistical Regularities: A Computational Single-Trial Analysis of the Mismatch Negativity.
    Weber LA; Diaconescu AO; Mathys C; Schmidt A; Kometer M; Vollenweider F; Stephan KE
    J Neurosci; 2020 Jul; 40(29):5658-5668. PubMed ID: 32561673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: implications for pathophysiology of executive dysfunction in schizophrenia.
    Wylie GR; Clark EA; Butler PD; Javitt DC
    Schizophr Bull; 2010 May; 36(3):585-94. PubMed ID: 18835838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory cortex responsiveness during talking and listening: early illness schizophrenia and patients at clinical high-risk for psychosis.
    Perez VB; Ford JM; Roach BJ; Loewy RL; Stuart BK; Vinogradov S; Mathalon DH
    Schizophr Bull; 2012 Nov; 38(6):1216-24. PubMed ID: 21993915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia.
    Anticevic A; Corlett PR; Cole MW; Savic A; Gancsos M; Tang Y; Repovs G; Murray JD; Driesen NR; Morgan PT; Xu K; Wang F; Krystal JH
    Biol Psychiatry; 2015 Mar; 77(6):569-80. PubMed ID: 25281999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurophysiological evidence of corollary discharge dysfunction in schizophrenia.
    Ford JM; Mathalon DH; Heinks T; Kalba S; Faustman WO; Roth WT
    Am J Psychiatry; 2001 Dec; 158(12):2069-71. PubMed ID: 11729029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reviewing the ketamine model for schizophrenia.
    Frohlich J; Van Horn JD
    J Psychopharmacol; 2014 Apr; 28(4):287-302. PubMed ID: 24257811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ketamine on brain function during response inhibition.
    Steffens M; Neumann C; Kasparbauer AM; Becker B; Weber B; Mehta MA; Hurlemann R; Ettinger U
    Psychopharmacology (Berl); 2018 Dec; 235(12):3559-3571. PubMed ID: 30357437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.